Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01575470 · ClinicalTrials.gov registry record · Phase 1
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells
A Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT01575470 is a Phase 1 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 25 participants.
The verdict
NCT01575470, a Phase 1 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if bone marrow harvest, BMMNC separation, and re-infusion in adults with acute severe TBI is safe and will improve functional outcome. 12/09/2015 Update: The study is closed to new enrollment and all follow-up visits have been completed. Data analysis is underway.
Interventions
- BIOLOGICAL autologous bone marrow mononuclear cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01575470
The ClinicalTrials.gov registry entry for NCT01575470 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which autologous bone marrow mononuclear cells is the first listed.
NCT01575470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01575470 about?
NCT01575470 is a clinical study titled "Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells". The purpose of this study is to determine if bone marrow harvest, BMMNC separation, and re-infusion in adults with acute severe TBI is safe and will improve functional outcome. 12/09/2015 Update: The study is closed to new enrollment and all follow-up visits have been completed. Data analysis is un...
What is the current status of trial NCT01575470?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2012-03. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01575470?
The interventions under investigation include: autologous bone marrow mononuclear cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT01575470?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.